199 related articles for article (PubMed ID: 36897349)
1. The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
Cai S; Lin N; Yang Y; Ma W; Wang Y; Lin X; Wang X; Zhao X
Eur Radiol; 2023 May; 33(5):3425-3434. PubMed ID: 36897349
[TBL] [Abstract][Full Text] [Related]
2. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
[TBL] [Abstract][Full Text] [Related]
3. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A
Radiology; 2020 Jan; 294(1):98-107. PubMed ID: 31743083
[TBL] [Abstract][Full Text] [Related]
4. Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.
Liu C; Sun Y; Yang Y; Feng Y; Xie X; Qi L; Liu K; Wang X; Zhu Q; Zhao X
Eur Radiol; 2021 Aug; 31(8):5840-5850. PubMed ID: 33533990
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
[TBL] [Abstract][Full Text] [Related]
7. Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?
Vernuccio F; Cannella R; Gozzo C; Greco V; Midiri M; Furlan A; Tang A; Brancatelli G
Abdom Radiol (NY); 2020 Aug; 45(8):2409-2417. PubMed ID: 32435849
[TBL] [Abstract][Full Text] [Related]
8. Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
Liu C; Shen Z; Ma H; Wang X; Wang X; Liu K; Wang X; Zhu Q; Zhao X
Eur Radiol; 2022 May; 32(5):3006-3015. PubMed ID: 34989839
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
[TBL] [Abstract][Full Text] [Related]
10. Gadobenate dimeglumine-enhanced magnetic resonance imaging can accurately predict the severity of esophageal varices and portal vein pressure in patients with hepatitis B cirrhosis.
Feng Q; Guan S; Zhao JR; Zhao XY; Zhang CC; Wang L; Feng YM; Li SL; Zhu Q
J Dig Dis; 2020 Feb; 21(2):104-111. PubMed ID: 31922658
[TBL] [Abstract][Full Text] [Related]
11. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
Ding F; Huang M; Ren P; Zhang J; Lin Z; Sun Y; Liang C; Zhao X
Eur Radiol; 2024 Apr; 34(4):2445-2456. PubMed ID: 37691080
[TBL] [Abstract][Full Text] [Related]
12. Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.
Frydrychowicz A; Nagle SK; D'Souza SL; Vigen KK; Reeder SB
J Magn Reson Imaging; 2011 Sep; 34(3):585-94. PubMed ID: 21751288
[TBL] [Abstract][Full Text] [Related]
13. The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis.
Cong L; Deng Y; Cai S; Wang G; Zhao X; He J; Zhao S; Wang L
Insights Imaging; 2024 Feb; 15(1):64. PubMed ID: 38411746
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
15. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA.
Vernuccio F; Bruno A; Costanzo V; Bartolotta TV; Vieni S; Midiri M; Salvaggio G; Brancatelli G
Curr Probl Diagn Radiol; 2020; 49(6):398-403. PubMed ID: 31253462
[TBL] [Abstract][Full Text] [Related]
17. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
Zhang W; Wang X; Miao Y; Hu C; Zhao W
Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
[TBL] [Abstract][Full Text] [Related]
18. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.
Feuerlein S; Gupta RT; Boll DT; Merkle EM
Eur J Radiol; 2012 Sep; 81(9):2037-41. PubMed ID: 21719224
[TBL] [Abstract][Full Text] [Related]
20. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O
Scand J Gastroenterol; 2016; 51(2):236-44. PubMed ID: 26357874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
